FDA inspection
TriRx Segre: FDA inspection ending Apr 23, 2026
FDA inspection 1316560 · Segre-En-Anjou Bleu
Key facts
| Inspection ID | 1316560 |
|---|---|
| Firm | TriRx Segre |
| FEI number | 1000537829 |
| Address | Zone Artisanale Segre La Grindoliere |
| City | Segre-En-Anjou Bleu |
| Fiscal year | 2026 |
| Inspection end date | Apr 23, 2026 |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data